As a company whose vision is around intersectionality, we aim to improve access to cancer clinical trials across UK. With access to a population of 20 Million who do not have easy access to cancer clinical trials we offer one clinical site spread across 8 dedicated state of the art research facilities in North of England.
Professor Wardley, an International key opinion leader Medical Oncology leads team of experienced clinicians who can
As a company whose vision is around intersectionality, we aim to improve access to cancer clinical trials across UK. With access to a population of 20 Million who do not have easy access to cancer clinical trials we offer one clinical site spread across 8 dedicated state of the art research facilities in North of England.
Professor Wardley, an International key opinion leader Medical Oncology leads team of experienced clinicians who can
Did you know by giving a donation of a regular amount, you could fund our clinicians to carry out ground breaking research that could improve cancer patient lives? – Yes its true.
Unlike corporate charities or organisations we do not invest in capital build projects but instead in people and skills enabling By sponsoring our clinicians allow them to continue to work with companies and the NHS in programmes focused around research and development of new drugs.
Your donation is used to fund the right people to grow research and access to treatments in your community.
Outreach Research & Innovation Group was established to improve access to cancer clinical trials across UK.
With access to a population of 20 Million who do not have easy access to cancer clinical trials we offer a new clinical site with 8 dedicated state of the art research facilities in North of England.
Professor Wardley, an International key opinion leader Medical Oncology leads team of experienced clinicians who can:
As a cross sector research hub we work with the NHS, Life Science Companies and private providers to treat patient’s in new and innovative ways increasing access to innovative treatments in your local community.
Speak to us today to implement cancer care services in your community to improve patient access.
An average of 28% of EU clinical trial applications have come from the UK (ABPI Clinical Trials Report 2019). This is only a fraction of the potential market opportunity open to the UK.
Speak to us today to increase your research opportunities, partnerships and portfolio to improve patient outcome performance.
Representing a community of over 137 countries, we bring product and service solutions to emerging markets in patient centered projects while unleashing private sector investment into research.
Speak to us today to join our international collaborations in cancer care research
Speak to our team today for a quote on how we can improve cancer care services in your region